Company / Capital Expenditures
Regenerative Medical Technology Group Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$602.6K
FY2025
5-year range
$198.4K / $602.6K
FY2021-FY2025
Trend
+179.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $385,596 to $602,583 over the past 2 years.
Based on SEC 10-K filings.
$602,583 in FY2025 with a 5-year CAGR of +43.2%.
Improved from $385,596 to $602,583 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +44.8%
- 5-Year CAGR
- +43.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +43.2%, indicating consistent growth.
- In FY2025, capital expenditures increased 179.7% year-over-year.
- Lowest capital expenditures in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $602.6K | +179.7% |
| FY2024 | $215.4K | -44.1% |
| FY2023 | $385.6K | +94.3% |
| FY2022 | $198.4K | - |
| FY2021 | - | - |
| FY2020 | $100.0K | +0.0% |
| FY2019 | $100.0K | +2400.0% |
| FY2018 | $4.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026